Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-05-01FULC3Power of Attorney for Section 16 Reporting Obligations
This filing is an exhibit, specifically a Limited Power of Attorney, for Section 16 Reporting Obligations. It designates Alex Sapir, Curt Oltmans, and Alan Musso as attorneys-in-fact for Joshua Lehrer-Graiwer, a director of Fulcrum Therapeutics, Inc. The attorneys-in-fact are authorized to execute and file all necessar...
Small CapBiotechnology
2026-05-01Fulcrum Therapeutics, Inc.3Power of Attorney for Section 16 Reporting ObligationsDuplicate
This filing is an exhibit, specifically a Limited Power of Attorney, for Section 16 Reporting Obligations. It designates Alex Sapir, Curt Oltmans, and Alan Musso as attorneys-in-fact for Joshua Lehrer-Graiwer, a director of Fulcrum Therapeutics, Inc. The attorneys-in-fact are authorized to execute and file all necessar...
Small CapBiotechnology
2026-05-01AVXL3Form 3 Filing - Axel Paeger Director Ownership Statement for Anavex Life Sciences Corp.
This is a Form 3 filing by Axel Paeger, a director of Anavex Life Sciences Corp. (AVXL), reporting his initial statement of beneficial ownership of securities. Filed on May 1, 2026, with a reporting period ending February 23, 2026, the document indicates that Paeger currently owns no securities in the company. The fili...
Small CapBiotechnology